<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; DNA Reasearch</title>
	<atom:link href="http://www.bioscreening.net/category/news/dna-reasearch/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Research at A&amp;M and Scripps finds HIV-killing compound</title>
		<link>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/</link>
		<comments>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 17:35:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1348</guid>
		<description><![CDATA[COLLEGE STATION - A powerful topical preventative for HIV, the virus that causes AIDS, could be a step closer to clinical trials, thanks to a newly discovered molecular compound that research at Texas A&#38;M University and the Scripps Research Institute shows dissolves the virus on contact. The ability of the synthetic compound known as &#8220;PD 404,182&#8243; [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Clears Abbott’s Confirmatory Chagas Disease Assay</title>
		<link>http://www.bioscreening.net/2011/11/22/first-clinical-trial-of-autologous-cardiac-stem-cells-shows-positive-results/</link>
		<comments>http://www.bioscreening.net/2011/11/22/first-clinical-trial-of-autologous-cardiac-stem-cells-shows-positive-results/#comments</comments>
		<pubDate>Tue, 22 Nov 2011 19:10:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[FDA News]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1340</guid>
		<description><![CDATA[FDA approved Abbott’s in vitro enzyme strip assay for Chagas disease. The Abbott ESA Chagastest detects antibodies to the causative pathogen Trypanosoma cruzi in serum or plasma samples. It is indicated for use as an additional, more specific test on human samples that have been found to be repeatedly reactive using a licensed screening test. The T. cruzi parasite is transmitted through contact with [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/22/first-clinical-trial-of-autologous-cardiac-stem-cells-shows-positive-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study: Shark Chemical May Protect Humans Against Viruses</title>
		<link>http://www.bioscreening.net/2011/09/20/study-shark-chemical-may-protect-humans-against-viruses/</link>
		<comments>http://www.bioscreening.net/2011/09/20/study-shark-chemical-may-protect-humans-against-viruses/#comments</comments>
		<pubDate>Tue, 20 Sep 2011 17:19:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1296</guid>
		<description><![CDATA[A chemical derived from sharks could help protect humans against viral infections such as hepatitis, American research out Tuesday showed. Scientists found that a chemical called squalamine demonstrated effective antiviral activity against a range of human viruses from yellow fever to hepatitis B, C and D, in both lab and animal experiments. As the chemical [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/20/study-shark-chemical-may-protect-humans-against-viruses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ark to Manufacture PsiOxus’ IV-Administered Oncolytic Virus for Clinical Trials</title>
		<link>http://www.bioscreening.net/2011/09/12/ark-to-manufacture-psioxus%e2%80%99-iv-administered-oncolytic-virus-for-clinical-trials/</link>
		<comments>http://www.bioscreening.net/2011/09/12/ark-to-manufacture-psioxus%e2%80%99-iv-administered-oncolytic-virus-for-clinical-trials/#comments</comments>
		<pubDate>Mon, 12 Sep 2011 20:06:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1282</guid>
		<description><![CDATA[Ark Therapeutics negotiated a manufacturing partnership with PsiOxus Therapeutics for the latter’s ColoAd1 candidate for the treatment of colorectal cancer. Under terms of the agreement Ark will work with PsiOxus to generate an IV formulation of the adenovirus-based oncolytic product using its suspension-based single-use system (ATOSUS) for toxicological and Phase I/II clinical studies. ColoAd1 is [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/12/ark-to-manufacture-psioxus%e2%80%99-iv-administered-oncolytic-virus-for-clinical-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Successes and New Technologies Revive Gene Therapy</title>
		<link>http://www.bioscreening.net/2011/09/09/clinical-successes-and-new-technologies-revive-gene-therapy/</link>
		<comments>http://www.bioscreening.net/2011/09/09/clinical-successes-and-new-technologies-revive-gene-therapy/#comments</comments>
		<pubDate>Fri, 09 Sep 2011 16:48:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1279</guid>
		<description><![CDATA[The prospect of curing human diseases by replacing a disease-related gene with a normal version remains the ultimate goal of gene therapy. But in its early days, attempts at gene therapy met with unpredictable and occasionally fatal outcomes. The field sustained a serious setback in 2000 following the death of 18-year old Jesse Gelsinger after [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/09/clinical-successes-and-new-technologies-revive-gene-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic Link Predisposes to Mesothelioma</title>
		<link>http://www.bioscreening.net/2011/08/29/genetic-link-predisposes-to-mesothelioma/</link>
		<comments>http://www.bioscreening.net/2011/08/29/genetic-link-predisposes-to-mesothelioma/#comments</comments>
		<pubDate>Mon, 29 Aug 2011 15:34:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1269</guid>
		<description><![CDATA[An investigation led by scientists at the University of Hawaii Cancer Center, Honolulu, and Fox Chase Cancer Center, Philadelphia has identified germline mutations in the BAP1 gene that predispose individuals to malignant mesothelioma. The research, published online yesterday in Nature Genetics, describes two U.S. families with a high incidence of mesothelioma, as well as other [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/29/genetic-link-predisposes-to-mesothelioma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Adding caffeine to sunscreen could guard against skin cancer</title>
		<link>http://www.bioscreening.net/2011/08/18/adding-caffeine-to-sunscreen-could-guard-against-skin-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/18/adding-caffeine-to-sunscreen-could-guard-against-skin-cancer/#comments</comments>
		<pubDate>Thu, 18 Aug 2011 16:18:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1257</guid>
		<description><![CDATA[Scientists have worked out how caffeine might protect against certain skin cancers – a finding that could lead to better sunscreens. The research, conducted in mice, suggests that caffeine changes the activity of a gene involved in the destruction of cells that have DNA damage and are therefore more likely to become cancerous. The scientists [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/18/adding-caffeine-to-sunscreen-could-guard-against-skin-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Blood Antibody May Signal Start of Ovarian Cancer</title>
		<link>http://www.bioscreening.net/2011/08/17/blood-antibody-may-signal-start-of-ovarian-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/17/blood-antibody-may-signal-start-of-ovarian-cancer/#comments</comments>
		<pubDate>Wed, 17 Aug 2011 18:49:38 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1253</guid>
		<description><![CDATA[WEDNESDAY, Aug. 17 (HealthDay News) &#8212; Researchers have found an antibody that might someday be useful in identifying women who have a higher risk of ovarian cancer, or possibly diagnosing early ovarian cancer. This particular antibody, which was detected in blood, develops as an immune system response to a protein called mesothelin. This protein is [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/17/blood-antibody-may-signal-start-of-ovarian-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Five Genes May Be Tied to Lethal Prostate Cancer</title>
		<link>http://www.bioscreening.net/2011/08/16/five-genes-may-be-tied-to-lethal-prostate-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/16/five-genes-may-be-tied-to-lethal-prostate-cancer/#comments</comments>
		<pubDate>Tue, 16 Aug 2011 18:42:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1250</guid>
		<description><![CDATA[TUESDAY, Aug. 16 (HealthDay News) &#8212; In what may be a diagnostic advance, U.S. and Swedish researchers have linked five inherited genetic mutations to the development of a particularly aggressive and deadly form of prostate cancer. The findings could someday lead to development of an easy-to-administer blood test to screen for such mutations to help [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/16/five-genes-may-be-tied-to-lethal-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Suicide-Bombing Bacteria Could Fight Infections</title>
		<link>http://www.bioscreening.net/2011/08/16/suicide-bombing-bacteria-could-fight-infections/</link>
		<comments>http://www.bioscreening.net/2011/08/16/suicide-bombing-bacteria-could-fight-infections/#comments</comments>
		<pubDate>Tue, 16 Aug 2011 18:38:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1248</guid>
		<description><![CDATA[Like any good military unit, infectious bacteria have access to numerous weapons and efficient communication systems. But like soldiers in the field, they&#8217;re also susceptible to suicide bombers. Researchers have used the tools of synthetic biology to create an Escherichia coli cell that can infiltrate foreign bacteria and explode, killing off the pathogens along with [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/16/suicide-bombing-bacteria-could-fight-infections/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MS genetic discovery casts doubt on vein theory</title>
		<link>http://www.bioscreening.net/2011/08/11/ms-genetic-discovery-casts-doubt-on-vein-theory/</link>
		<comments>http://www.bioscreening.net/2011/08/11/ms-genetic-discovery-casts-doubt-on-vein-theory/#comments</comments>
		<pubDate>Thu, 11 Aug 2011 17:01:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1245</guid>
		<description><![CDATA[Scientists have discovered 29 new genetic variations linked to multiple sclerosis, with many involving genes relevant to the immune system – a finding that they say bolsters the theory that MS is a primarily an autoimmune disease. The new study, published Wednesday in the journal Nature, is the largest-ever study on the genetics of multiple [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/11/ms-genetic-discovery-casts-doubt-on-vein-theory/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New tests screen for gum disease, oral cancer</title>
		<link>http://www.bioscreening.net/2011/08/10/new-tests-screen-for-gum-disease-oral-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/10/new-tests-screen-for-gum-disease-oral-cancer/#comments</comments>
		<pubDate>Wed, 10 Aug 2011 15:10:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1242</guid>
		<description><![CDATA[Future dental visits may involve more than a simple cleaning. Oral DNA testing may also help screen patients for gum disease or oral cancer. Dr. Jessica Lawson of Urbandale Family Dentistry began offering the tests last spring. Two tests involve gum disease and a third for oral human papillomavirus, or HPV, assesses risks for oral [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/10/new-tests-screen-for-gum-disease-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic mutations cause schizophrenia</title>
		<link>http://www.bioscreening.net/2011/08/08/genetic-mutations-cause-schizophrenia/</link>
		<comments>http://www.bioscreening.net/2011/08/08/genetic-mutations-cause-schizophrenia/#comments</comments>
		<pubDate>Mon, 08 Aug 2011 15:28:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1239</guid>
		<description><![CDATA[More than 50 per cent of sporadic cases of schizophrenia are caused by new, or &#8220;de novo,&#8221; protein-altering mutations-genetic errors that are present in patients but not in their parents, a new research has shown. A group led by Maria Karayiorgou, MD, and Joseph A. Gogos, MD, PhD, examined the genomes of patients with schizophrenia [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/08/genetic-mutations-cause-schizophrenia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Urine Test May Help Detect, Stratify Prostate Cancer</title>
		<link>http://www.bioscreening.net/2011/08/04/urine-test-may-help-detect-stratify-prostate-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/04/urine-test-may-help-detect-stratify-prostate-cancer/#comments</comments>
		<pubDate>Thu, 04 Aug 2011 15:07:23 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1235</guid>
		<description><![CDATA[In men with elevated prostate specific antigen (PSA), an investigational urine test can detect and stratify prostate cancer, researchers reported. The test is based on the detection of a gene fusion that is specific to prostate cancer, combined with another marker, according to Arul Chinnaiyan, MD, PhD, of the University of Michigan Medical School in [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/04/urine-test-may-help-detect-stratify-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Proteus Syndrom Gene Variant Identified</title>
		<link>http://www.bioscreening.net/2011/07/28/proteus-syndrom-gene-variant-identified/</link>
		<comments>http://www.bioscreening.net/2011/07/28/proteus-syndrom-gene-variant-identified/#comments</comments>
		<pubDate>Thu, 28 Jul 2011 15:34:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1219</guid>
		<description><![CDATA[Researchers have discovered the gene mutation that leads to Proteus syndrome, a condition that causes different parts of the body to grow faster and larger than others, HealthDay reports. With only about 500 cases known in the developed world, Proteus syndrome is rare. The condition is marked by a partial enlargement of the hands or [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/28/proteus-syndrom-gene-variant-identified/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Studies Show Natural Protein May Provide Benefits Against Stroke up to 12 Hours After Onset</title>
		<link>http://www.bioscreening.net/2011/07/27/studies-show-natural-protein-may-provide-benefits-against-stroke-up-to-12-hours-after-onset/</link>
		<comments>http://www.bioscreening.net/2011/07/27/studies-show-natural-protein-may-provide-benefits-against-stroke-up-to-12-hours-after-onset/#comments</comments>
		<pubDate>Wed, 27 Jul 2011 20:38:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1216</guid>
		<description><![CDATA[Scientists suggest that treating stoke patients with an endogenous immunomodulatory neuroprotectant protein, ?B-crystallin (Cryab), could help limit brain damage even if first administered 12 hours after the onset of stroke. Studies by a Stanford University School of Medicine team in a mouse model of stroke found that administering Cryab to animals 12 hours after stroke [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/27/studies-show-natural-protein-may-provide-benefits-against-stroke-up-to-12-hours-after-onset/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Smelly socks tested in Tanzania as way to prevent malaria</title>
		<link>http://www.bioscreening.net/2011/07/14/smelly-socks-tested-in-tanzania-as-way-to-prevent-malaria/</link>
		<comments>http://www.bioscreening.net/2011/07/14/smelly-socks-tested-in-tanzania-as-way-to-prevent-malaria/#comments</comments>
		<pubDate>Thu, 14 Jul 2011 15:49:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1213</guid>
		<description><![CDATA[In global public health, disease-fighting tools that are cheap, available and sustainable are the Holy Grail. It might be hard to top the one being tested in Tanzania as a way to prevent malaria: smelly socks. Experiments in three villages where people get about 350 bites a year from malaria-infected mosquitoes are using dirty socks [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/14/smelly-socks-tested-in-tanzania-as-way-to-prevent-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Discover Gonorrhea Resistant to Antibiotics</title>
		<link>http://www.bioscreening.net/2011/07/12/scientists-discover-gonorrhea-resistant-to-antibiotics/</link>
		<comments>http://www.bioscreening.net/2011/07/12/scientists-discover-gonorrhea-resistant-to-antibiotics/#comments</comments>
		<pubDate>Tue, 12 Jul 2011 15:11:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1208</guid>
		<description><![CDATA[(EndPlay Staff Reports) &#8211; A new untreatable strain of gonorrhea has been discovered in Japan and is causing concern in the United States. Scientists reported that the strain, which is named H041, is resistant to all known forms of antibiotics. The researchers discussed the findings at a Monday meeting in Canada about three days after [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/12/scientists-discover-gonorrhea-resistant-to-antibiotics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Who wants to live forever? Scientist sees aging cured</title>
		<link>http://www.bioscreening.net/2011/07/05/who-wants-to-live-forever-scientist-sees-aging-cured/</link>
		<comments>http://www.bioscreening.net/2011/07/05/who-wants-to-live-forever-scientist-sees-aging-cured/#comments</comments>
		<pubDate>Tue, 05 Jul 2011 15:56:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[Stem Cell Research]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1197</guid>
		<description><![CDATA[(Reuters) &#8211; If Aubrey de Grey&#8217;s predictions are right, the first person who will live to see their 150th birthday has already been born. And the first person to live for 1,000 years could be less than 20 years younger. A biomedical gerontologist and chief scientist of a foundation dedicated to longevity research, de Grey [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/05/who-wants-to-live-forever-scientist-sees-aging-cured/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemophilia Is Target of Therapy on Genome</title>
		<link>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/</link>
		<comments>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/#comments</comments>
		<pubDate>Mon, 27 Jun 2011 15:13:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1184</guid>
		<description><![CDATA[Researchers using a new technique for editing the genome of living cells have shown that they can cure hemophilia in mice, at least in principle, with a couple of injections that carry out the “cut” and “paste” operations needed to insert a corrective gene. This is the first time this genome-editing technique has succeeded in [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

